Form 4: Organon & Co. Executive Joseph T. Morrissey, Jr. Reports Stock Transactions
SEC Form 4 Filing
Joseph T. Morrissey, Jr., Head of Manufacturing at Organon & Co., reports the vesting of restricted stock units and subsequent stock transactions on May 4, 2024.
Summary
- On May 4, 2024, Joseph T. Morrissey, Jr., Head of Manufacturing at Organon & Co., had restricted stock units (RSUs) vest, which converted into 3,604 shares of Organon common stock.
- Following the vesting, Morrissey disposed of 1,568 shares of common stock at a price of $19.61 per share to cover tax obligations.
- After these transactions, Morrissey directly owns 40,838 shares of Organon common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions, with no inherent positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.
Stakeholder Impact
- The transactions have a minimal impact on shareholders, reflecting routine executive compensation adjustments.
Key Dates
| Date | Description |
|---|---|
| 05/04/2022 | One-third of the RSUs vested. |
| 05/04/2023 | One-third of the RSUs vested. |
| 05/04/2024 | One-third of the RSUs vested; stock transactions occurred. |
| 05/07/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.